Articles citing this paper
Acceptability of oral and topical HIV chemoprophylaxis in India: implications for at-risk women and men who have sex with men
Nomita Chandhiok A D , Smita N. Joshi B and Raman Gangakhedkar C
+ Author Affiliations
- Author Affiliations
A Indian Council of Medical Research, Ansari Nagar, New Delhi 110029, India.
B Hirabai Cowasji Jehangir Medical Research Institute, Jehangir Hospital Premises, 32 Sassoon Road, Pune 411001, India.
C National AIDS Research Institute, Bhosari, Pune 411026, India.
D Corresponding author. Email: n_chandhiok@hotmail.com
Sexual Health 11(2) 171-179 https://doi.org/10.1071/SH13067
Submitted: 1 May 2013 Accepted: 28 July 2013 Published: 11 October 2013
9 articles found in Crossref database.
Perspectives on HIV Prevention Among Urban Black Women: A Potential Role for HIV Pre-Exposure Prophylaxis
Flash Charlene A.,
Stone Valerie E.,
Mitty Jennifer A.,
Mimiaga Matthew J.,
Hall Kathryn T.,
Krakower Douglas, Mayer Kenneth H.
AIDS Patient Care and STDs. 2014 28(12). p.635
Acceptability of HIV Pre-Exposure Prophylaxis (PrEP) and Implementation Challenges Among Men Who Have Sex with Men in India: A Qualitative Investigation
Chakrapani Venkatesan,
Newman Peter A.,
Shunmugam Murali,
Mengle Shruta,
Varghese Jarvis,
Nelson Ruban, Bharat Shalini
AIDS Patient Care and STDs. 2015 29(10). p.569
PrEP implementation in the Asia‐Pacific region: opportunities, implementation and barriers
Zablotska Iryna,
Grulich Andrew E,
Phanuphak Nittaya,
Anand Tarandeep,
Janyam Surang,
Poonkasetwattana Midnight,
Baggaley Rachel,
van Griensven Frits, Lo Ying‐Ru
Journal of the International AIDS Society. 2016 19(7S6).
Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men
Carballo-Diéguez Alex,
Giguere Rebecca,
Dolezal Curtis,
Leu Cheng-Shiun,
Balán Iván C.,
Brown William,
Rael Christine,
Richardson Barbra A.,
Piper Jeanna M.,
Bekker Linda-Gail,
Chariyalertsak Suwat,
Chitwarakorn Anupong,
Gonzales Pedro,
Holtz Timothy H.,
Liu Albert,
Mayer Kenneth H.,
Zorrilla Carmen D.,
Lama Javier R.,
McGowan Ian, Cranston Ross D.
AIDS and Behavior. 2017 21(12). p.3336
Bringing new HIV infections to zero – opportunities and challenges offered by antiretroviral-based prevention in Asia, the Pacific and beyond: An overview of this special issue
Zablotska Iryna B.,
Whittaker Bill,
de Wit John,
Kamarulzaman Adeeba,
Ananworanich Jintanat,
Wright Edwina,
Poynten Isobel Mary, Mayer Kenneth
Sexual Health. 2014 11(2). p.97
Understanding the Acceptability of Broadly Neutralizing Antibodies for HIV Prevention Among At-Risk Populations and Feasibility Considerations for Product Introduction in India: Protocol for a Qualitative Study
Mukherjee Joyeeta,
Rawat Shruta,
ul Hadi Saif,
Aggarwal Pritha,
Chakrapani Venkatesan,
Rath Pratyasha,
Manchi Pallavi,
Aylur Srikrishnan,
Malhotra Shelly,
Keane Margaret, Gangaramany Alok
JMIR Research Protocols. 2024 13 p.e47700
Global implementation of PrEP as part of combination HIV prevention - Unsolved challenges
Cáceres Carlos F,
Bekker Linda-Gail, Godfrey-Faussett Peter
Journal of the International AIDS Society. 2016 19 p.21479
Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey
Belludi Ashwin,
McFall Allison M.,
Solomon Sunil Suhas,
Celentano David D.,
Mehta Shruti H.,
Srikrishnan A. K.,
Kumar M. Suresh,
Solomon Suniti,
Lucas Gregory M., Patel Rupa R.
PLOS ONE. 2021 16(2). p.e0247352
Acceptability of PrEP among MSM and transgender communities—Qualitative findings from two metropolitan cities in India
Ramanaik Satyanarayana,
Sinha Anju Pradhan,
Mukherjee Aparna,
Pujar Ashwini,
Subramanyam Kalyani,
Gopalan Anjali,
Washington Reynold, Newman Peter A.
PLOS ONE. 2023 18(2). p.e0281984
